Intel Price Target LOWERED and 4 Stock Analyses Not to Overlook

JPMorgan Chase & Co. (NYSE:JPM) stock decline after its trading losses was overdone, according to RBC Capital. The firm keeps an Outperform rating and a $50 price target on the stock.

Don’t Miss: Wall Street Brief: Yahoo Finds NEW CEO, Chevron Gets LUCKY. 

Salesforce.com (NYSE:CRM): Following the company’s second set of outages during the past few weeks during which time the stocks fell 5%, JMP Securities has reported that the latest outage seems to be the result of a brief power outage at an Equinix (NASDAQ:EQIX) facility. The firm keeps an Outperform rating and a $170 price target on the shares.

Intel Corporation (NASDAQ:INTC): According to Nomura, the aggressive pricing on Core i3 Ivy Bridge parts as well as price cuts intended for support of reduced Ultrabooks price points will create soft ASPs. The firm thinks shares of Intel have been trading premium to cash flow causing the firm to give the stock a Reduce rating and $25 price target.

Hologic Inc. (NASDAQ:HOLX) shares possess two major drivers, Gen Prob and tomosythesis, claims William Blair. The firm also believes the company’s updated last night was a positive, and the tomosythesis update was positive in respect to backlog and placements. The firm maintains an Outperform rating on the stock. On the other hand, Hologic preannounced a Q3 revenue miss, and Cantor credits this to 3D tomo unit installation delays. Cantor shows concern regarding Hologic’s Hologic’s Gen-Probe (NASDAQ:GPRO) deal’s near-term outlook. The firm keeps a Hold rating on the stock.

Investing Insights: Fastenal Earnings CHEAT SHEET: Double-Digit Growth AGAIN! 

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.